Pillstats
Rx only · Injection · Intravenous

Tranexamic Acid

Tranexamic Acid

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)10691
US makers7 labelers
Packages11
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.109$0.218$0.327$0.436Jun 2025May 2026Jul 2026
$0.379
Latest avg · Jul 22, 2026
+9%
Since Jun 18, 2025
7
Active US suppliers
45%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1352704055412025 Q12025 Q22025 Q32025 Q42026 Q1
467
Rx · 2026 Q1
31K
Units dispensed
+137%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Armas Pharmaceuticals Inc.unknown3SUPPLYING
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.unknown2SUPPLYING
Micro Labs Limitedunknown2SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING
Baxter Healthcare Corporationunknown1SUPPLYING
NorthStar Rx LLCunknown1SUPPLYING
Caplin Steriles Limitedunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.